Besix eye drop is for topical ophthalmic use only and not for injection into the eye. It belongs to a class of quinolone antimicrobial drugs used to treat bacterial conjunctivitis caused by susceptive bacteria. Bacterial conjunctivitis is a common ocular infection, and in severe cases, it may cause vision complications. However, most cases can be managed with antibiotic therapy. A topical antibiotic is considered the first-line treatment for this eye infection. Besix eye drop containing Besivance 0.6%, a fluoroquinolone discovered specifically for ocular use and approved for the management of bacterial conjunctivitis. It kills certain bacteria that cause this ocular infection. As with other anti-infective medications, prolonged use of this ophthalmic formulation may result in the overgrowth of fungi. In the case of superinfection, drug discontinuation should be considered under the doctor’s supervision. Patients should be advised not to wear contact lenses if they are dealing with symptoms of bacterial conjunctivitis or during the treatment with Besivance ophthalmic solution. Quinolone antibiotics have been associated with hypersensitivity reactions even while a patient is following a single dose treatment. Patients should be instructed to discontinue treatment immediately and contact their ophthalmologist for initial rash symptoms or an allergic reaction.

Reviews
There are no reviews yet.